Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Explore the primary drivers of risk in Dividend Aristocrats ETF, including sector shifts and interest-rate impacts, with practical mitigation tips.
26,217 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A high-conviction bet on a Chinese logistics platform faced a sharp stock drop. This article explains why the fund wa...
As stocks climb, a warning from the former chair of the Federal Reserve signals risk ahead. This guide explains the t...
A key Fed signal is rippling through crypto markets. This guide explains what happened, which cryptocurrencies may be...
Lawmakers warn that granting a national bank charter to a crypto-focused issuer could undermine financial integrity a...
Bitcoin stalls Ethereum flashes signal shifting tides in crypto markets. This guide breaks down the latest weekly sig...
The crypto market has seen a meaningful pullback in 2026, creating potential bargains for patient investors. This gui...
A new set of futures is coming to the CME Group, tying Tesla and SpaceX to a cash-settled futures contract. This arti...
Geopolitical shocks echoed through crypto flows as Iranian exchanges saw a dramatic outflow spike totaling $10.3 mill...
XRP has fallen sharply in recent months. This guide explains the risks and how to decide if down months can become ba...
A fresh, per-capita violence ranking shifts attention away from familiar conflict zones, signaling new risk dynamics ...
Bitmine Immersion Technologies stock jumped on Monday as new crypto exposure details surfaced. This in-depth guide br...